Literature DB >> 31867075

Reverse Warburg Effect-Related Mitochondrial Activity and 18F-FDG Uptake in Invasive Ductal Carcinoma.

Byung Wook Choi1, Young Ju Jeong2, Sung Hwan Park2, Hoon Kyu Oh3, Sungmin Kang1.   

Abstract

PURPOSE: We evaluated the relationship between fluorine-18 fluoro-2-deoxy-glucose (18F-FDG) uptake and mitochondrial activity in cancer cells and investigated the prognostic implications of this relationship in patients with invasive ductal carcinoma of the breast (IDCB).
METHODS: One hundred forty-six patients with primary IDCB who underwent preoperative 18F-FDG PET/CT followed by curative surgical resection were enrolled in the current study. Mitochondrial activity of cancer cells was assessed based on translocase of outer mitochondrial membrane 20 (TOMM20) expression and cytochrome C oxidase (COX) activity. A Pearson's correlation analysis was used to assess the relationship between the maximum standardized uptake value of the primary tumour (pSUVmax) and mitochondrial activity. Clinicopathological factors, including pSUVmax, histological grade, oestrogen receptor (ER), progesterone receptor (PR), and TOMM20 expression; and COX activity, were assessed for the prediction of disease-free survival (DFS) using the Kaplan-Meier method and Cox proportional hazards model.
RESULTS: Fourteen of the 146 subjects (9.6%) showed tumour recurrence. There was a significant positive correlation between 18F-FDG uptake and the mitochondrial activity of cancer cells in patients with IDCB, and increased 18F-FDG uptake and mitochondrial activity were significantly associated with a shorter DFS. Additionally, results from the receiver-operating curve analysis demonstrated that the cut-off values of pSUVmax, TOMM20 expression, and COX activity for the prediction of DFS were 7.76, 4, and 5, respectively. Further, results from the univariate analysis revealed that pSUVmax, TOMM20 expression, PR status, and histologic grade were significantly associated with DFS; however, the multivariate analysis revealed that only pSUVmax was associated with DFS (HR, 6.51; 95% CI, 1.91, 22.20; P = 0.003).
CONCLUSIONS: The assessment of preoperative 18F-FDG uptake and post-surgical mitochondrial activity may be used for the prediction of DFS in patients with IDCB. © Korean Society of Nuclear Medicine 2019.

Entities:  

Keywords:  18F-FDG; Breast cancer; Cytochrome c oxidase; Invasive ductal carcinoma; Reverse Warburg effect; Translocase of outer mitochondrial membrane 20

Year:  2019        PMID: 31867075      PMCID: PMC6898688          DOI: 10.1007/s13139-019-00613-x

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  43 in total

Review 1.  Targeting lactate metabolism for cancer therapeutics.

Authors:  Joanne R Doherty; John L Cleveland
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.

Authors:  Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Neal Flomenberg; Ruth C Birbe; Agnieszka K Witkiewicz; Anthony Howell; Stephanos Pavlides; Aristotelis Tsirigos; Adam Ertel; Richard G Pestell; Paolo Broda; Carlo Minetti; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

4.  Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors.

Authors:  Ubaldo E Martinez-Outschoorn; Zhao Lin; Casey Trimmer; Neal Flomenberg; Chenguang Wang; Stephanos Pavlides; Richard G Pestell; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

5.  Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

Authors:  Shigeto Ueda; Hitoshi Tsuda; Hideki Asakawa; Takashi Shigekawa; Kazuhiko Fukatsu; Nobuo Kondo; Mikio Yamamoto; Yukihiro Hama; Katsumi Tamura; Jiro Ishida; Yoshiyuki Abe; Hidetaka Mochizuki
Journal:  Jpn J Clin Oncol       Date:  2008-04       Impact factor: 3.019

6.  Role for glucose transporter 1 protein in human breast cancer.

Authors:  M Grover-McKay; S A Walsh; E A Seftor; P A Thomas; M J Hendrix
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

7.  Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells.

Authors:  Federica Sotgia; Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Ahmed F Salem; Aristotelis Tsirigos; Rebecca Lamb; Sharon Sneddon; James Hulit; Anthony Howell; Michael P Lisanti
Journal:  Cell Cycle       Date:  2012-11-21       Impact factor: 4.534

8.  Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.

Authors:  Ana María García Vicente; Ángel Soriano Castrejón; Alberto León Martín; Ignacio Chacón López-Muñiz; Vicente Muñoz Madero; María del Mar Muñoz Sánchez; Azahara Palomar Muñoz; Ruth Espinosa Aunión; Ana González Ageitos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-30       Impact factor: 9.236

Review 9.  The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy.

Authors:  Yaojie Fu; Shanshan Liu; Shanghelin Yin; Weihong Niu; Wei Xiong; Ming Tan; Guiyuan Li; Ming Zhou
Journal:  Oncotarget       Date:  2017-05-25

Review 10.  Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.

Authors:  Cory D Bovenzi; James Hamilton; Patrick Tassone; Jennifer Johnson; David M Cognetti; Adam Luginbuhl; William M Keane; Tingting Zhan; Madalina Tuluc; Voichita Bar-Ad; Ubaldo Martinez-Outschoorn; Joseph M Curry
Journal:  Biomed Res Int       Date:  2015-12-08       Impact factor: 3.411

View more
  2 in total

Review 1.  Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK.

Authors:  Nurbubu T Moldogazieva; Innokenty M Mokhosoev; Alexander A Terentiev
Journal:  Cancers (Basel)       Date:  2020-04-02       Impact factor: 6.639

2.  Low levels of AMPK promote epithelial-mesenchymal transition in lung cancer primarily through HDAC4- and HDAC5-mediated metabolic reprogramming.

Authors:  Shoujie Feng; Li Zhang; Xiucheng Liu; Guangbin Li; Biao Zhang; Ziwen Wang; Hao Zhang; Haitao Ma
Journal:  J Cell Mol Med       Date:  2020-06-09       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.